Skip to content

Clinical trials

Phase 2 Myeloproliferative Disorders trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Phase 2 Country / region: France Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20052
20071
20131
20141
20151
20171
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation2
Cogent Biosciences, Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
Fred Hutchinson Cancer Center1
Institut Paoli-Calmettes1
Novartis Pharmaceuticals1
PV-Nord1
Sierra Oncology LLC - a GSK company1
Takeda1
Vion Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders11
Leukemia5
Hematologic Diseases4
Leukemia, Myeloid, Acute4
Leukemia, Myelomonocytic, Chronic4
Polycythemia Vera4
Bone Marrow Diseases3
Congenital Abnormalities3
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative3
Leukemia, Myeloid, Chronic-Phase3

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.